Reversed-phase determination of famotidine, potential degradates, and preservatives in pharmaceutical formulations by high-performance liquid chromatography using silica as a stationary phase
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 363 (2) , 243-249
- https://doi.org/10.1016/s0021-9673(01)83743-2
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Analytical method for the quantification of famotidine, an H2-receptor blocker, in plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- STUDIES ON MK-208 (YM-11170) A NEW, SLOWLY DISSOCIABLE H-2-RECEPTOR ANTAGONIST1983
- Separation of organic amine compounds on silica gel with reversed-phase eluentsAnalytical Chemistry, 1982
- EFFECT OF A NEW POTENT H-2-BLOCKER, 3-[[[2-[(DIAMINOMETHYLENE)AMINO]-4-THIAZOLYL]METHYL]-THIO]-N-2-SULFAMOYLPROPIONAMIDINE (YM-11170) ON GASTRIC-SECRETION INDUCED BY HISTAMINE AND FOOD IN CONSCIOUS DOGS1982
- High-Performance liquid chromatographic determination of biogenic aminesJournal of Chromatography A, 1981
- Reversed-phase ion-pair high-performance liquid chromatography of drugs and related compounds using underivatized silica as the stationary phaseJournal of Chromatography A, 1979